Erythroid-Specific Expression of LIN28A Is Sufficient for Robust Gamma-Globin Gene and Protein Expression in Adult Erythroblasts

Authors

  • Y. Terry Lee Author
  • Jaira F. de Vasconcellos Author
  • Colleen Byrnes Author
  • Megha Kaushal Author
  • Antoinette Rabel Author
  • Laxminath Tumburu Author
  • Joshua M. Allwardt Author
  • Jeffery L. Miller Author

Keywords:

Life Sciences & Biotechnology

Abstract

Increasing fetal hemoglobin (HbF) levels in adult humans remains an active area in hematologic research. Here we explored erythroid-specific LIN28A expression for its effect in regulating gamma-globin gene expression and HbF levels in cultured adult erythroblasts. For this purpose, lentiviral transduction vectors were produced with LIN28A expression driven by erythroid-specific gene promoter regions of the human KLF1 or SPTA1 genes. Transgene expression of LIN28A with a linked puromycin resistance marker was restricted to the erythroid lineage as demonstrated by selective survival of erythroid colonies (greater than 95% of all colonies). Erythroblast LIN28A over-expression (LIN28A-OE) did not significantly affect proliferation or inhibit differentiation. Greater than 70% suppression of total let-7 microRNA levels was confirmed in LIN28A-OE cells. Increases in gamma-globin mRNA and protein expression with HbF levels reaching 30–40% were achieved. These data suggest that erythroblast targeting of LIN28A expression is sufficient for increasing fetal hemoglobin expression in adult human erythroblasts.

Publication information

Originally published in PLOS ONE on 2015-12-16. Original DOI: 10.1371/journal.pone.0144977.

The original full text is available here under CC0 1.0. The displayed publication date is the original publication date.

Downloads

Original publication date

2015-12-16

Issue

Section

Research Articles